Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements
Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors m...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Martinón-Torres, Federico [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures - Hatamzadeh, Yaser ELSEVIER, 2021, official publication of the Society for Adolescent Medicine, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:59 ; year:2016 ; number:2 ; pages:12-20 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jadohealth.2016.03.041 |
|---|
| Katalog-ID: |
ELV024754552 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV024754552 | ||
| 003 | DE-627 | ||
| 005 | 20230625143422.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jadohealth.2016.03.041 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016018000029.pica |
| 035 | |a (DE-627)ELV024754552 | ||
| 035 | |a (ELSEVIER)S1054-139X(16)30015-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 380 |a 330 |q VZ |
| 100 | 1 | |a Martinón-Torres, Federico |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements |
| 264 | 1 | |c 2016transfer abstract | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. | ||
| 520 | |a Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. | ||
| 650 | 7 | |a Societal consequences |2 Elsevier | |
| 650 | 7 | |a Disease burden |2 Elsevier | |
| 650 | 7 | |a Meningococcal disease |2 Elsevier | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Hatamzadeh, Yaser ELSEVIER |t Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures |d 2021 |d official publication of the Society for Adolescent Medicine |g Amsterdam [u.a.] |w (DE-627)ELV005917751 |
| 773 | 1 | 8 | |g volume:59 |g year:2016 |g number:2 |g pages:12-20 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jadohealth.2016.03.041 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2016 |e 2 |h 12-20 |g 9 |y 59.2016, 2, S12-, (9 S.) | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
f m t fmt |
|---|---|
| matchkey_str |
martinntorresfederico:2016----:eihrnteudnfeigccadsaeovninlnud |
| hierarchy_sort_str |
2016transfer abstract |
| publishDate |
2016 |
| allfields |
10.1016/j.jadohealth.2016.03.041 doi GBVA2016018000029.pica (DE-627)ELV024754552 (ELSEVIER)S1054-139X(16)30015-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 380 330 VZ Martinón-Torres, Federico verfasserin aut Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements 2016transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. Societal consequences Elsevier Disease burden Elsevier Meningococcal disease Elsevier Enthalten in Elsevier Science Hatamzadeh, Yaser ELSEVIER Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures 2021 official publication of the Society for Adolescent Medicine Amsterdam [u.a.] (DE-627)ELV005917751 volume:59 year:2016 number:2 pages:12-20 extent:9 https://doi.org/10.1016/j.jadohealth.2016.03.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 59 2016 2 12-20 9 59.2016, 2, S12-, (9 S.) 045F 610 |
| spelling |
10.1016/j.jadohealth.2016.03.041 doi GBVA2016018000029.pica (DE-627)ELV024754552 (ELSEVIER)S1054-139X(16)30015-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 380 330 VZ Martinón-Torres, Federico verfasserin aut Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements 2016transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. Societal consequences Elsevier Disease burden Elsevier Meningococcal disease Elsevier Enthalten in Elsevier Science Hatamzadeh, Yaser ELSEVIER Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures 2021 official publication of the Society for Adolescent Medicine Amsterdam [u.a.] (DE-627)ELV005917751 volume:59 year:2016 number:2 pages:12-20 extent:9 https://doi.org/10.1016/j.jadohealth.2016.03.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 59 2016 2 12-20 9 59.2016, 2, S12-, (9 S.) 045F 610 |
| allfields_unstemmed |
10.1016/j.jadohealth.2016.03.041 doi GBVA2016018000029.pica (DE-627)ELV024754552 (ELSEVIER)S1054-139X(16)30015-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 380 330 VZ Martinón-Torres, Federico verfasserin aut Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements 2016transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. Societal consequences Elsevier Disease burden Elsevier Meningococcal disease Elsevier Enthalten in Elsevier Science Hatamzadeh, Yaser ELSEVIER Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures 2021 official publication of the Society for Adolescent Medicine Amsterdam [u.a.] (DE-627)ELV005917751 volume:59 year:2016 number:2 pages:12-20 extent:9 https://doi.org/10.1016/j.jadohealth.2016.03.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 59 2016 2 12-20 9 59.2016, 2, S12-, (9 S.) 045F 610 |
| allfieldsGer |
10.1016/j.jadohealth.2016.03.041 doi GBVA2016018000029.pica (DE-627)ELV024754552 (ELSEVIER)S1054-139X(16)30015-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 380 330 VZ Martinón-Torres, Federico verfasserin aut Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements 2016transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. Societal consequences Elsevier Disease burden Elsevier Meningococcal disease Elsevier Enthalten in Elsevier Science Hatamzadeh, Yaser ELSEVIER Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures 2021 official publication of the Society for Adolescent Medicine Amsterdam [u.a.] (DE-627)ELV005917751 volume:59 year:2016 number:2 pages:12-20 extent:9 https://doi.org/10.1016/j.jadohealth.2016.03.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 59 2016 2 12-20 9 59.2016, 2, S12-, (9 S.) 045F 610 |
| allfieldsSound |
10.1016/j.jadohealth.2016.03.041 doi GBVA2016018000029.pica (DE-627)ELV024754552 (ELSEVIER)S1054-139X(16)30015-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 380 330 VZ Martinón-Torres, Federico verfasserin aut Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements 2016transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. Societal consequences Elsevier Disease burden Elsevier Meningococcal disease Elsevier Enthalten in Elsevier Science Hatamzadeh, Yaser ELSEVIER Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures 2021 official publication of the Society for Adolescent Medicine Amsterdam [u.a.] (DE-627)ELV005917751 volume:59 year:2016 number:2 pages:12-20 extent:9 https://doi.org/10.1016/j.jadohealth.2016.03.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 59 2016 2 12-20 9 59.2016, 2, S12-, (9 S.) 045F 610 |
| language |
English |
| source |
Enthalten in Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures Amsterdam [u.a.] volume:59 year:2016 number:2 pages:12-20 extent:9 |
| sourceStr |
Enthalten in Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures Amsterdam [u.a.] volume:59 year:2016 number:2 pages:12-20 extent:9 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Societal consequences Disease burden Meningococcal disease |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures |
| authorswithroles_txt_mv |
Martinón-Torres, Federico @@aut@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV005917751 |
| dewey-sort |
3610 |
| id |
ELV024754552 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024754552</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625143422.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jadohealth.2016.03.041</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016018000029.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024754552</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1054-139X(16)30015-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">380</subfield><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Martinón-Torres, Federico</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Societal consequences</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Disease burden</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Meningococcal disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Hatamzadeh, Yaser ELSEVIER</subfield><subfield code="t">Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures</subfield><subfield code="d">2021</subfield><subfield code="d">official publication of the Society for Adolescent Medicine</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV005917751</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:59</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:12-20</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jadohealth.2016.03.041</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">59</subfield><subfield code="j">2016</subfield><subfield code="e">2</subfield><subfield code="h">12-20</subfield><subfield code="g">9</subfield><subfield code="y">59.2016, 2, S12-, (9 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Martinón-Torres, Federico |
| spellingShingle |
Martinón-Torres, Federico ddc 610 ddc 380 Elsevier Societal consequences Elsevier Disease burden Elsevier Meningococcal disease Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements |
| authorStr |
Martinón-Torres, Federico |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV005917751 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 380 - Commerce, communications & transportation 330 - Economics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 380 330 VZ Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements Societal consequences Elsevier Disease burden Elsevier Meningococcal disease Elsevier |
| topic |
ddc 610 ddc 380 Elsevier Societal consequences Elsevier Disease burden Elsevier Meningococcal disease |
| topic_unstemmed |
ddc 610 ddc 380 Elsevier Societal consequences Elsevier Disease burden Elsevier Meningococcal disease |
| topic_browse |
ddc 610 ddc 380 Elsevier Societal consequences Elsevier Disease burden Elsevier Meningococcal disease |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| hierarchy_parent_title |
Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures |
| hierarchy_parent_id |
ELV005917751 |
| dewey-tens |
610 - Medicine & health 380 - Commerce, communications & transportation 330 - Economics |
| hierarchy_top_title |
Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV005917751 |
| title |
Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements |
| ctrlnum |
(DE-627)ELV024754552 (ELSEVIER)S1054-139X(16)30015-5 |
| title_full |
Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements |
| author_sort |
Martinón-Torres, Federico |
| journal |
Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures |
| journalStr |
Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
12 |
| author_browse |
Martinón-Torres, Federico |
| container_volume |
59 |
| physical |
9 |
| class |
610 610 DE-600 380 330 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Martinón-Torres, Federico |
| doi_str_mv |
10.1016/j.jadohealth.2016.03.041 |
| dewey-full |
610 380 330 |
| title_sort |
deciphering the burden of meningococcal disease: conventional and under-recognized elements |
| title_auth |
Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements |
| abstract |
Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. |
| abstractGer |
Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. |
| abstract_unstemmed |
Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
2 |
| title_short |
Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements |
| url |
https://doi.org/10.1016/j.jadohealth.2016.03.041 |
| remote_bool |
true |
| ppnlink |
ELV005917751 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1016/j.jadohealth.2016.03.041 |
| up_date |
2024-07-06T22:15:39.118Z |
| _version_ |
1803869632981893120 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024754552</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625143422.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jadohealth.2016.03.041</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016018000029.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024754552</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1054-139X(16)30015-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">380</subfield><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Martinón-Torres, Federico</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Invasive meningococcal disease remains a substantial global public health burden despite being vaccine-preventable worldwide. More than one million cases are reported annually, with average fatality rates ranging from 10% to 40% depending on clinical presentation and geographic location. Survivors may suffer debilitating sequelae that reduce the quality of life for the patient and family members responsible for their care. Major financial burdens are associated with acute treatment and follow-up care, and outbreak management often places extensive financial strains on public health resources. Although the clinical and financial aspects of meningococcal disease burden are straightforward to quantify, other burdens such as lifelong cognitive deficits, psychological stress, adaptive measures for reintegration into society, familial impact, and legal costs are systematically overlooked. These and other facets of disease burden are therefore not systematically considered in cost-effectiveness analyses that public health authorities take into consideration when making decisions regarding vaccination programs. Changing the approach for measuring meningococcal disease burden is necessary to accurately understand the societal consequences of this devastating illness. In this article, the conventional and under-recognized burdens of meningococcal disease are presented and discussed.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Societal consequences</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Disease burden</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Meningococcal disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Hatamzadeh, Yaser ELSEVIER</subfield><subfield code="t">Working commuters’ tendency toward a travel pattern with potentially more walking: Examining the relative influence of personal and environmental measures</subfield><subfield code="d">2021</subfield><subfield code="d">official publication of the Society for Adolescent Medicine</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV005917751</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:59</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:12-20</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jadohealth.2016.03.041</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">59</subfield><subfield code="j">2016</subfield><subfield code="e">2</subfield><subfield code="h">12-20</subfield><subfield code="g">9</subfield><subfield code="y">59.2016, 2, S12-, (9 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.399328 |